Outsourcing: Analysis and developments of contract service providers to the pharmaceutical and biotechnology industries - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Outsourcing
Contract manufacturing organizations (CMOs) and contract research organizations (CROs). Global sourcing of pharma ingredients and services. Trends and challenges for the biopharmaceutical and pharmaceutical industries.

Fast Locator: 2013-2014 Europe and Asia

August 1, 2013

Fast Locator: 2013-2014 Europe and Asia

Fast Locator 2013-2014 Index

August 1, 2013

View companies' outsourcing profiles from PharmTech's 2013 Outsourcing Resources Fast Locator Index in the following categories.

Fast Locator Index 2013-2014: API Production Technologies

August 1, 2013

Fast Locator Index 2013-2014: API Production Technologies

Strengthening the Supply Chain for Pharmaceutical Ingredients

July 2, 2013

Pharmaceutical Technology

The US and EU move forward with measures to fortify the pharmaceutical supply chain.

Q&A with Claudia Roth, President, Vetter Development Service, USA

July 2, 2013
Pharmaceutical Technology

Claudia Roth, President of Vetter Development Service USA, discusses trends in single-use technology for clinical manufacturing.

What Happened to Outsourcing in Asia?

July 2, 2013

Pharmaceutical Technology

The industry may not be ready for India and China as regulatory issues emerge.

Gauging Investment in High-Potency Manufacturing

July 2, 2013

Pharmaceutical Technology

Contract service providers expand capabilities in API and finished product manufacturing to meet demand for high-potency drugs.

Drug Approval Trends Don't Extend to CMOs

June 2, 2013

Pharmaceutical Technology

Approvals of new drugs are on an upward swing, but only a few CMOs are benefiting.

Outsourcing's Modest Role as a Cost-Containment Strategy

May 2, 2013

Pharmaceutical Technology

Outsourcing is weighing in more as a tactic for cost-cutting, but it is still not the primary weapon.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
9%
All of the above.
45%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here